AstraZeneca Is Moving the Needle
This drugmaker is making a historic upside breakout. Let's check the charts.
Biogen's Japanese Partner on Alzheimer's Drug Set for Gains
Eisai is working on another promising drug candidate to combat Alzheimer's disease, and will benefit from a split of the profits for Aduhelm.
Moderna's Charts Are Bullish and Pointed Higher
Here's the area where I would like to go long MRNA.
Is It Too Late to Buy Progyny?
A Real Money subscriber asks. We answer.
As America Grows Older, So Does the Appeal of This Dividend REIT
Omega Healthcare offers a 7% yield and promise of growth.
An Updated Technical Strategy for HCA Healthcare
Let's review the charts and indicators.
Jim Cramer: Google's Healthcare Deal With HCA Is Huge
The great thing about Google? Unlike IBM? It isn't trumpeting anything. It's just talking about algorithms, let the eyes glaze over.
Anthem's Charts Look Pretty Healthy
We are again recommending the long side of ANTM, and here are some prices to watch.
Centene Finally Looks Ready to Make a Move Higher
Let's review the charts and indicators.
We Have New Price Targets on Bullish-Looking AbbVie
The charts and indicators of ABBV are pointed higher.